Evaluation of the Washington Intensive Supervision Program
Recruitment status was Recruiting
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
This study entails an evaluation of the Washington Intensive Supervision Program (WISP). The purpose of the evaluation is to test whether subjects assigned to WISP perform better than those assigned to parole-as-usual (PAU).
| Condition | Intervention |
|---|---|
|
Behavior Drug Users |
Behavioral: WISP supervision Behavioral: Parole-as-usual |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label |
| Official Title: | Evaluation of the Washington Intensive Supervision Program |
- Revocation rate [ Time Frame: 12 months ] [ Designated as safety issue: No ]Percentage of subjects in each condition who are revoked from parole and returned to prison
- % positive drug tests [ Time Frame: 12 months ] [ Designated as safety issue: No ]Percentage of random and scheduled drug tests that test positive for illicit drugs
- Days incarcerated [ Time Frame: 12 months ] [ Designated as safety issue: No ]Total number of days incarcerated in jail or prison
- % Missed appointments [ Time Frame: 12 months ] [ Designated as safety issue: No ]Percentage of parole appointments that are missed.
- New arrests [ Time Frame: 12 months ] [ Designated as safety issue: No ]Number of new arrests.
- Assessed risk [ Time Frame: 12 months ] [ Designated as safety issue: No ]Parolee risk assessment (high, medium, low)
| Estimated Enrollment: | 70 |
| Study Start Date: | January 2011 |
| Estimated Study Completion Date: | June 2012 |
| Estimated Primary Completion Date: | January 2012 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: WISP supervision
Parolee supervised under WISP parole model.
|
Behavioral: WISP supervision
WISP entails a warning session (Orientation Hearing) where the rules of parole are laid out and parolees are told that any violation of stated parole conditions will be sanctioned with a brief jail term (typically a few days in jail). WISP includes regular random drug testing.
Other Name: HOPE supervision
|
|
Active Comparator: Parole-as-usual
Parolees supervised under Washington State's parole-as-usual
|
Behavioral: Parole-as-usual
Parolees are supervised under standard parole supervision practice in Washington State.
Other Name: PAU
|
Detailed Description:
This study entails an evaluation of the Washington Intensive Supervision Program (WISP). WISP is a program targeting high-risk parolees in Seattle, and is modeled after the HOPE program in Hawaii. The purpose of the evaluation is to test whether subjects assigned to WISP perform better than those assigned to parole-as-usual (PAU) on a number of outcomes, including drug use, missed appointments, recidivism, prison and jail stays, and parole revocations. WISP uses regular random drug testing and close community supervision, paired with swift and certain, but modest sanctions for every detected violation.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Male |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Inmates released by DOC to community corrections supervision
- Supervised out of the Seattle CJC (Community Justice Center) to include field offices and offenders from the downtown "Metro" unit, Southeast Seattle unit, Northgate (north Seattle) and West Seattle.
- Have a parole supervision discharge date at least one year from the date of release from entry into WISP
Exclusion Criteria:
- Level III Sex Offenders
- Existing assignment to supervision that precludes WISP. These include: Drug Offender Sentencing Alternative (DOSA)and Special Sex Offender Sentencing Alternative (SSOSA).
- Dangerously Mentally Ill (DMIO)
Contacts and Locations| Contact: Donta Harper | 206-516-7709 | |
| Contact: Kimberli Dewing |
| United States, Washington | |
| Seattle Community Justice Center | Recruiting |
| Seattle, Washington, United States | |
| Contact: Donta Harper 206-516-7709 | |
| Contact: Linda Bonazza 206-516-7709 | |
| Principal Investigator: | Angela Hawken, PHD | Pepperdine University |
More Information
No publications provided
| Responsible Party: | Angela Hawken, Pepperdine University |
| ClinicalTrials.gov Identifier: | NCT01343472 History of Changes |
| Other Study ID Numbers: | SPP0311F08 |
| Study First Received: | April 26, 2011 |
| Last Updated: | April 27, 2011 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Pepperdine University:
|
Behavior Drug users |
ClinicalTrials.gov processed this record on May 16, 2013